E2F transcription factors are key targets of the retinoblastoma (Rb) tumor suppressor. Despite extensive studies, the in vivo consequences of disrupting the interaction between Rb and an individual E2F are not clear. Here, we report an E2F mutation that interfered with binding to Rb family proteins without significantly affecting protein level or transactivation function. Characterization of mouse embryonic fibroblasts with this Rb-independent E2F3 LQ mutation revealed that disrupting the Rb and E2F3 interaction increased cell proliferation, allowed cells to accumulate to higher density, and significantly altered expression of genes involved in metabolism, inflammation, immunity, and response to stress. These results suggest that the Rb-independent E2F LQ mutations might provide useful tools to investigate the in vivo consequences of disrupting the interactions between Rb and E2F.
The retinoblastoma (Rb) tumor suppressor is a member of the Rb family that is often inactivated in cancers. The functions of Rb are believed to be mediated by the binding of Rb to a large number of cellular targets, particularly the E2F family of transcription factors [1] . The E2F proteins can be subdivided into three groups: activating, repressive, and Rb-independent [2, 3] . There are three activating E2Fs (E2F1-3) in mammalian systems but only one activating E2F (dE2F1) in Drosophila. Generally speaking, Rb regulates E2F target gene expression both by binding to E2F, particularly the activating E2F proteins, and by recruiting the chromatin-modifying enzymes to regulate target gene expression [4] . Genome-wide studies have revealed diverse functions of E2F targets, including DNA replication and repair, cell cycle regulation, cell cycle checkpoint, cell death, differentiation [5, 6] .
While the large numbers of E2F targets potentially explain the diverse functions of Rb in the cell, particularly those related to the cell cycle, there are conflicting results about the roles of free E2F proteins (E2F proteins that were not bound by the Rb proteins) and their contribution to Rb inactivation-induced developmental and tumor phenotypes. On the one hand, removing the transcriptional activation function of dE2F1 has been shown to rescue the lethality of fly Rb (rbf) mutant, resulting in the development of adult flies with normal-looking appendages [7] . Similarly, inactivation of either E2F1 or E2F3 can partially suppress the developmental defects of Rb À/À mice phenotypes and suppress the pituitary tumor incidence of Rb +/À mice [8] [9] [10] [11] . Furthermore, the Rb1 R654W/+ mutation, which corresponds to the Rb R661W mutation identified from low penetrance Rbs, reduced the ability to bind E2F and promoted pituitary tumor development similar to the Rb +/À mutation [12] [13] [14] . These results suggest that inhibition of E2F activity is the critical function of Rb in normal and cancer development in both fly and mammalian systems. On the other hand, loss of either E2F1 or E2F3 in mice can also promote the development of certain cancers, suggesting that the activating E2F proteins also have tumor suppressor function [9, 11] . In addition, the Rb ΔG mutation, which disrupts the binding between Rb and the E2F transcription activation domain, does not cause spontaneous tumor development despite deregulated E2F target gene expression and accelerated G1/S transition after serum induction [15] . As cells with Rb mutations will have multiple free activating E2F, loss of Rb and repressive E2F4 complex, increased expression of Rb family member p107, which can bind activating E2F proteins in the absence of Rb [15, 16] , we still do not know the exact in vivo consequences of having individual free activating E2F despite extensive studies of the Rb and E2F proteins. One approach to study the role of free E2F in vivo is to use E2F mutations that specifically disrupt the interaction with the Rb family of proteins without other effects. However as the Rb binding domain of E2F overlaps with its transcription activation domain [17] , such E2F mutants can be difficult to identify. dE2F1 su89 was identified as an allele of dE2F1 that suppressed phenotypes of RBF overexpression [18] . Sequence analysis revealed that dE2F1 su89 has a point mutation in the conserved Rb binding domain of dE2F1 that changes a conserved Leu to Gln. Because the Rb binding domain of E2F overlaps with the transcription activation domain, mutations in this domain often also impacted the ability of E2F to activate transcription. Interestingly, the dE2F1 su89 mutation disrupts dE2F1's interaction with RBF without affecting the transcription activation function and causes deregulated E2F target expression, particularly in regions with high dE2F1 levels such as the morphogenetic furrow of developing eye disk [18] . Therefore, dE2F1 su89 lost its regulation by RBF, which we referred to as Rb family-independent E2F. As dE2F1 su89 contains a single point mutation of the conserved L786 in the Rb binding domain of dE2F1, it is likely that the same point mutation in the corresponding mammalian activating E2F proteins will also generate the mammalian Rb-independent E2Fs, which potentially provide ideal tools to characterize the consequences of disrupting the interactions between an individual E2F and the Rb family of proteins without affecting the function of other Rb targets.
In this study, we introduced the LQ mutation into the Rb binding domain of mammalian activating E2F proteins and showed that the LQ mutation impairs the ability of E2F proteins to bind Rb binding without significantly affecting the protein levels or the ability to activate transcription. We further introduced the LQ mutation into mouse E2F3, generated the corresponding E2F3 LQ mouse embryonic fibroblasts (MEFs), and characterized the consequences of having the Rb family-independent E2F3 at cellular level.
Materials and methods

Plasmid construction
To make p107 (aa379-1104) expression construct, p107 (aa379-1104) was amplified by the primers p107 forward: 5 0 -GGCGGATCCGAAAGAAGCAGTCATTACTCC-3 0 and p107 reverse: 5 0 -GGCGGATCCCCTTACCTTAGAAGGG CTGC-3 0 . The PCR fragments were digested and cloned into pET15b vector (Novagen, Billerica, MA, USA).
To make E2F1 L415Q-mutant construct, fragment N was amplified by primers CMV forward: 5 0 -CCTACAG CTCCTGGGCAACG-3 0 and E2F1 L415Q-mutant reverse: 5 0 -GCCCTCCTCCTGGCCGAAGTGG-3 0 . Fragment C was amplified by primers E2F1 L415Q forward: 5 0 -CCAC TTCGGCCAGGAGGAGGGC-3 0 and CMV reverse: 5 0 -AAGTCAAGGCTTTTCTATGG-3 0 . The whole mutant fragment was amplified using fragment N and C mixture as a template by the CMV primers. The final PCR product was digested by BamHI and ligated into vector pCMV-HA-Bam. The wild-type (WT) E2F1 was amplified by CMV primers and cloned into pCMV-HA-Bam vector.
For E2F2 L416Q construct, fragment N was amplified by primers E2F2 forward: 5 0 -GACGGATCCATGCTGCAAG GGC-3 0 and E2F2 L416Q-mutant reverse: 5 0 -CACCCGC CTCCTGGCCCCACAGG-3 0 . Fragment C was amplified by E2F2 L416Q-mutant forward: 5 0 -CCTGTGGGGCC AGGAGGCGGGTG-3 0 and pGEX-2T BamHI reverse: 5 0 -GGCGGATCCCACCCAACTGATCTTCAGCATC-3 0 . The whole mutant fragment was amplified using fragment N and C mixture as a template by the primers E2F2 forward and pGEX-2T BamHI reverse. The final PCR product was digested by BamHI and cloned into pCMV-HA-Bam vector. The E2F2 was amplified by primers E2F2 forward and pGEX-2T BamHI reverse and cloned into pCMV-HA-Bam vector.
For E2F3 L438Q construct, fragment N was amplified by primers E2F3a CDS forward: 5 0 -CGTGGATCCGC CACCATGGACAAAAGGGCACTG-3 0 and E2F3a L438Q-mutant reverse: 5 0 -CCTCCTCCCCCTGGCTCAGG AGATAG-3 0 . Fragment C was amplified by E2F3a L438Qmutant forward: 5 0 -CTATCTCCTGAGCCAGGGGGAG GAGG-3 0 and pGEX-2T BamHI reverse. The whole mutant fragment was amplified using fragment N and C mixture as a template by the primers E2F3a CDS forward and pGEX-2T BamHI reverse. The final PCR product was digested by BamHI and cloned into pCMV-HA-Bam vector. The E2F3 was amplified by the primers E2F3a CDS forward and E2F3a CDS reverse: 5 0 -CGTGGATCCTCAACTACACAT GAAGTCTTCC-3 0 . The PCR product was digested by BamHI and cloned into pCMV-HA-Bam vector. All above constructs were verified by sequencing.
GST-pRb (aa379-928) is from the previous study [19] .
Generation of E2F3 LQ/+ mice
To generate E2F3 LQ -knockin mice, C57B6/T mouse ES cells were electroporated with the E2F3 targeting vectors shown in Fig. 3A . ES cells were selected by G418 by Southern blotting. Southern blot probes were generated from PCR amplification. Primers used: 5 0 probe forward: 5 0 -AGACCAGCCCTTCTACATAATGAG-3 0 , 5 0 probe reverse: 5 0 -TGGACTCTCTTCTTCAAATCTCAGG-3 0 ; 3 0 probe forward: 5 0 -TTCTGCTGCTCGAAGCTGTTG-3 0 , 3 0 probe reverse: 5 0 -ACCTGACCGCATCCTGAGAAG-3 0 . The ES clones with the desired E2F3 mutation were injected into blastocysts in the transgenic core facility to generate chimeras, which were back-crossed to generate mice with germline transmission. Germline-transmitted mice were bred with Mox2Cre mice [20] , to remove the floxed neocassette and generate mice with only the targeted E2F3 LQ mutation. To further validate the mutations introduced in E2F3 LQ mice, we sequenced E2F3 mRNA from E2F3 LQ/LQ MEFs derived from the mice, and only the desired point mutations were found. The offspring were genotyped by PCR. The following primers were used: E2F3 LQ forward: 5 0 -GACGTCGACTGGCTGTGTCTTAAC CAAATGC-3 0 , E2F3 LQ reverse: 5 0 -CGTGACGCGG CCGCAGGACACAGATCACCATTAGGC-3 0 ; Cre common primer: 5 0 -GGGACCACCTTCTTTTGGCTTC-3 0 , Cre WT primer: 5 0 -AAGATGTGGAGAGTTCGGGGT AG-3 0 , Cre-mutant primer: 5 0 -CCAGATCCTCCTCA GAAATCAGC-3 0 . All animals were housed and treated in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Chicago.
Generation of E2F3 LQ/LQ MEFs and cell culture
Mouse embryonic fibroblast cells were isolated from 13.5-day-old embryos from E2F3 LQ/+ mice intercross according to the standard procedures. MEF and HEK293 cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated FBS and 50 unitsÁmL À1 penicillin/streptomycin.
Protein purification
GST-pRb was purified as described [21] . Purified protein was dialyzed for 2 h at 4°C in dialysis buffer (25 mM Tris pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol). The concentration was determined by the OD280 and the calculated protein extinction coefficients. The protein was aliquoted and kept at À80°C.
HIS-p107 construct was transformed into BL21 (DE3). The single colonies were inoculated and grown at 30°C. Bacteria pellet was resuspended in lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole, pH 8.0). After sonication, the supernatant was incubated with NI-NTA beads for 2 h. The mixture was loaded into a disposable column. After washing with wash buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 20 mM imidazole, pH 8.0), HIS-tagged proteins were eluted with elution buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, pH 8.0). The eluted protein was then dialyzed and determined as GST-pRb protein.
Fluorescence polarization binding assay
The fluorescence polarization assay was carried out according to Ref. [22] . Briefly, Tamra-labeled E2F1 WT peptide (5-TAMRA-EALDYHFGLEEGEGIRDLFDCDFG; United BioSystems, Herndon, VA, USA) and E2F1-mutant peptide (5-TAMRA-EALDYHFGQEEGEGIRDLFDCDFG; Peptide 2.0, Chantilly, VA, USA) were dissolved in assay buffer (20 mM HEPES, 100 mM KCl, 0.1% Tween-20, 5 mM DTT, pH 7.8), diluted to 100 nM, and plated into black 384-well plates (Thermo Fisher Scientific, Waltham, MA, USA) at 1 lL per well. Purified proteins were serially diluted 1 : 2 into buffer for 11 times. For the interaction assay, 9 lL of each protein concentrations was added to the peptide-containing 384-well plates resulting in a final volume of 10 lL. The samples were incubated for 20 min in the dark at room temperature, and fluorescence polarization was measured by Analyst GT multimode reader (Molecular Devices, Sunnyvale, CA, USA) with excitation and emission wavelengths of 530 nm and 590 nm, respectively. Experimental values were output as millipolarization units and imported into Excel file where Michaelis-Menten kinetics equation was used to determine dissociation constants (K d ) for each protein/peptide pairing by least-squares nonlinear regression.
Transient transfection
Cells from the exponential growth phase were seeded into plates the day before transfection. The cells were transfected by calcium phosphate coprecipitation method or PolyJet (SignaGen Laboratories, Rockville, MD, USA). After the cells were exposed to the transfection mixture for 6 h, the medium was replaced with fresh medium. The cells were incubated for 48 h before the cells were harvested for assay.
Transcriptional reporter assay
Cells were plated into 24-well plate to reach 70% confluence. The cells were transfected with indicated transfection mixture. Cell extracts were prepared at 48 h post-transfection, and the luciferase activity was measured using Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA) according to the manufacturer's protocol. Luciferase activity was read on a BD Monolight 3010 Luminometer (BD Biosciences, San Jose, CA, USA). All data points presented are the average measurement of three independent transfections.
Western blot and IP
For western blot, cell or tissue samples were lysed in RIPA buffer (50 mM Tris/HCl pH 8.0, 150 mM NaCl, 0.1% SDS, and 0.5% Na deoxycholate, 1% NP-40) with fresh proteinase inhibitor. Western blot data were acquired using a Li-Cor Odyssey image reader. The following antibodies were used: b-actin (AC-15, dilution 1 : 3000; Santa Cruz, Dallas, TX, USA), E2F3 (C-18, dilution 1 : 1000; Santa Cruz), pRb (4.1, 1 : 10; Hybridoma bank, Iowa City, IA, USA), HA (12CA5, dilution 1 : 10), goat anti-mouse IRDye (dilution 1 : 10 000; Li-Cor, Lincoln, NE, USA).
For immunoprecipitation (IP) experiments, cells were lysed in NP40 buffer (50 mM Tris/Cl pH 8.0, 150 mM NaCl, 5 mM EDTA, 15 mM MgCl 2 , 1 mM DTT, 0.1 mM NaF, 1% NP-40) with fresh protease inhibitors. The clear supernatant was incubated with primary antibody for 2 h at 4°C. After incubation, prewashed Protein G beads (GE healthcare, Little Chalfont, UK) were added to the samples, and the mixture was incubated for additional 2 h at 4°C. After the incubation, the beads were intensely washed. Then, the beads were mixed with loading buffer and boiled for western blot.
BrdU labeling
Passage 4 MEF cells were plated on coverslips in six-well plates. After 48 h, the cells were washed twice with 19 PBS and then incubated in DMEM containing 0.1% FBS for 72 h. Then, the cells were fed with DMEM containing 10% FBS. At each time point, the cells were incubated with medium containing 3 mgÁmL À1 BrdU for 2 h at 37°C. The cells were fixed and permeabilized as described [23] . After denaturing DNA with 2 N HCl, the cells were incubated with mouse anti-BrdU antibody (G3G4, dilution 1 : 20, Hybridoma Bank). FITC antimouse secondary antibody (dilution 1 : 200, Jackson ImmunoResearch, West Grove, PA, USA) was used for detection.
Cell cycle analysis
Cells were collected and fixed in cold 70% ethanol. The fixed cells were treated with RNase for 30 min and then stained with propidium iodide (PI) solution (Sigma, St. Louis, MO, USA) at room temperature. Approximately 10 000/sample cells were analyzed using LSRII 3-8 flow cytometer and FACSDIVA software (BD Biosciences, San Jose, CA, USA).
RNA isolation and qRT-PCR
Total RNA was isolated from cells or mouse tissue using TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. 2 lg of total RNA was reverse-transcribed using M-MLV reverse transcriptase (Promega) and random primers. PCR was performed in triplicate using SYBR green mix (Biotool, Houston, TX, USA) qPCR condition used: 3 min at 95°C followed by 45 cycles of 95°C for 20 s, 60°C for 30 s, and 65°C for 1 min. The primers are listed in Table S3 .
Microarray analysis
Cells were cultured and collected in the indicated condition. Total RNA was extracted with miRNeasy Mini Kit (Qiagen, Hilden, Germany). Microarray was carried out with Illumina Mouse WG-6 array at the functional genomics facility at the University of Chicago. Illumina GenomeStudio module for gene expression analysis was used to analyze the microarray data.
The microarray data have been deposited to the GEO database. Accession number is GEO GSE102379.
Statistics P values were determined using the Student's unpaired t-test.
Result and Discussion
An L-to-Q mutation in the conserved Rb binding domain impairs the binding between E2F1 peptide and the Rb family proteins Alignment of the Rb binding domain of E2F revealed that the Leu mutated in dE2F1 su89 is highly conserved in all the activating and repressive E2F proteins ( Fig. 1A) [18] . Our previous report showed that the LQ mutation disrupted the interaction between fly dE2F1 and fly Rb without significantly affecting dE2F1 protein levels, the binding to dDP, and the ability to activate transcription [18] . Indeed, dE2F1 su89 can activate E2F target gene expression even in the presence of overexpressed fly Rb. Therefore, the LQ mutation in dE2F1 su89 renders it Rb-independent. We hypothesized that the same LQ mutation in the conserved mammalian activating E2F proteins may have similar effects.
To characterize the effects of the LQ mutation in mammalian E2F proteins, we first compared the effect of this LQ mutation on the binding between the E2F1 C-terminal peptides and Rb family proteins using the fluorescence polarization binding assay [24] .
Synthesized TAMRA-labeled WT or L415Q-mutant E2F1 peptides were incubated with purified Rb family proteins pRb or p107 and the level of fluorescence polarization was determined. The K d was calculated and used for comparing the binding activity. Consistent with the fact that E2F1 binds preferentially to Rb than to p107 [25] , the K d between WT E2F1 peptide and pRb was around 3 lM, while the K d between WT E2F1 peptide and p107 was 7 lM (Fig. 1B,C) . Interestingly, the K d between the LQ-mutant peptide and Rb was 20 lM (Fig. 1B) , indicating that the LQ mutation significantly interfered the binding between the E2F1 peptide and Rb protein in vitro. Furthermore, the K d between the E2F1 LQ-mutant peptide and p107 was 200 lM (Fig. 1C) , indicating that the LQ mutation has even more dramatic effect on the binding of E2F1 to the Rb family protein p107. Therefore, the LQ mutation significantly interferes the interaction between the E2F1 peptide and Rb family proteins in vitro.
The L-to-Q mutation interferes the binding between all the activating E2F proteins and Rb
There are three activating E2F proteins, E2F1-3, in mammalian cells. To further characterize whether the same LQ mutation affects the binding of these activating E2F with Rb in the context of full-length E2F proteins, we generated full-length human E2F1 L415Q -, E2F2 L416Q -, and E2F3 L438Q -expressing constructs as well as the corresponding WT controls. HEK293T cells were cotransfected with Rb and WT or mutant E2F LQ constructs and the binding between Rb and E2F was determined by IP and western blot experiments. As shown in Fig. 2A -C, while WT and LQ-mutant forms of E2F were expressed at similar levels, WT but not the LQ-mutant forms of E2F1, 2, and 3 were significantly brought down by Rb IP ( Fig. 2A-C) . Therefore, the LQ mutation interfered the binding between Rb and all the activating E2Fs in the full-length context.
The LQ mutation does not affect the ability of E2F proteins to activate transcription
The Rb binding domain of E2F overlaps with the transactivation domain. Mutations in E2F that interfere its binding to Rb often affect its ability to activate transcription. We further tested the effect of LQ mutations on the ability of E2F to activate transcription and on their regulation by Rb. WT or LQmutant E2F were transfected into HEK293 cells with or without cotransfected Rb and the level of an E2F reporter activity was measured. In the absence of cotransfected Rb, WT and LQ-mutant version of E2F1, E2F2, or E2F3 induced similar level of E2F reporter activation ( Fig. 2D-F ). In addition, while Rb significantly inhibited transactivation by WT E2F, the ability of Rb to inhibit transactivation by the E2F1 LQ -, E2F2 LQ -, or E2F3 LQ -mutant proteins was significantly impaired (Fig. 2D-F) . Taken together, these results indicate that the LQ mutations in E2F1, E2F2, and E2F3 do not affect their transcription activation function but significantly impairs their binding to and regulation by the Rb family of proteins.
Generation of the E2F3 LQ -knockin MEFs
The above results suggest that the LQ mutation of E2F provides the perfect model to characterize the in vivo consequences of disrupting the Rb and activating E2F interaction. E2F3 is known to regulate cellular proliferation and previous studies showed that loss of E2F3 decreased proliferation in MEFs [26] . Therefore, we generated an E2F3 LQ -knockin construct, which includes the LQ mutation, a nearby EcoRV site, and a neomycin cassette (Fig. 3A) . After electroporation and G418 selection, correctly targeted E2F3 LQ ES cell lines were identified by Southern blot (Fig. 3B) . Two independent ES cell lines (#3 and #172) were used and generated two independent lines of E2F3 LQ -knockin mouse. The germline E2F3 LQ/+ mice were further crossed with Mox2Cre mice to excise the neomycin selection marker. The different genotypes were identified by PCR of genomic DNA (Fig. 3C ). The LQ mutation in the E2F3 mice was also confirmed by sequencing, which clearly showed the targeted mutation of L (CTG) to Q (CAG; Fig. 3D ). The E2F3 LQ/LQ -mutant mice are viable and can be obtained at Mendelian ratio. E2F3 LQ/LQ and WT littermate control embryos were obtained from E2F3 LQ/+ crosses at embryonic day 13.5 and were used to generate E2F3 LQ/LQ and WT control MEFs.
E2F3 LQ/LQ MEF cells showed increased expression of E2F target genes, early onset of DNA synthesis after serum stimulation
Western blot results showed that E2F3 LQ mutation did not significantly affect the E2F3 protein levels (Fig. 4A) . IP/western blot results showed that significantly decreased level of Rb was coimmunoprecipitated with anti-E2F3 antibody in the E2F3 LQ/LQ MEFs (Fig. 4A) . These observations confirm that the E2F3 LQ mutation significantly impairs its interaction with Rb at endogenous protein levels. Consistent with this, transfection of an E2F reporter into the WT or E2F3 LQ MEFs showed that E2F3 LQ MEFs exhibited increased E2F activity (Fig. 4B ). As the best known E2F target genes include DNA replication factors and cell cycle regulators, are generally repressed in G1, and induced at G1/S transition, we further examined the effect of E2F3 LQ mutation on expression of such genes in 72-h serum-starved WT or E2F3 LQ MEFs. Indeed, the expressions of known E2F regulated genes involved in cell cycle control and DNA replication, such as Cyclin E, Cyclin A2, Cdk1, Pcna, Dhfr, Tk, Mcm2/3/6/7, Cdt1, Chaf1a/b, Rpa2, Lig1, and Nasp, were all significantly increased in the E2F3 LQ MEFs compared to the WT control MEFs (Fig. 4E,F) .
Previous studies showed that Rb À/À MEFs enter S phase earlier than WT control after serum stimulation [27] and the E2F3 À/À MEFs showed delayed G1/S transition and reduced rate of DNA synthesis [26] . Therefore, we further characterized the effect of E2F3 LQ mutation on the rate of S-phase entry and cell proliferation. WT and E2F3 LQ MEFs were serum-starved for 72 h and then stimulated to enter the cell cycle by the addition of serum. BrdU incorporation was used to follow WT and E2F3 LQ MEF cell cycle entry. Significant levels of BrdU incorporation was first detected at 16 h after serum addition in WT MEFs, which peaked at 24 h. In contrast, significantly higher levels of BrdU-incorporating cells were observed in the E2F3 LQ MEFs at 16 h (over 35% in E2F3 LQ MEFs compared with 15% in WT MEFs; Fig. 4C,D) . These data suggest that the Rb family-independent E2F3 is sufficient to promote earlier onset of DNA synthesis after serum stimulation. E2F3 LQ/LQ MEF cells proliferate faster, reach higher cell density, and have increased expression of genes involved in metabolism, inflammation, and response to stress In our attempt using 3T3 protocol to establish the spontaneously immortalized cells from WT and E2F3 LQ MEFs, we noticed that the E2F3 LQ MEFs appear to proliferate faster and accumulated more cells. Cell cycle analysis of the WT and E2F3 LQ MEFs showed that the E2F3 LQ MEFs had reduced proportion of G1 cells and increased proportion of S/G2 cells ( Fig. 5O-P) . In addition, determination of the cell proliferation rate confirmed that the E2F3 LQ MEFs exhibit significantly increased rate of cell proliferation and reached higher cell density than that of WT MEFs when cultured under either high-or low-density conditions ( Fig. 5A,B ). The increased cell proliferation of the E2F3 LQ MEFs also made it easier to establish the E2F3 LQ cell lines based on 3T3 protocol.
The higher rate of cell proliferation and increased cell density suggest that E2F3 LQ affects other functions in addition to cell cycle and DNA replication.
Microarray experiments were carried out using RNA from asynchronously proliferating WT and E2F3 LQ MEFs. A total of 134 genes were found to show significantly increased expression in E2F3 LQ MEFs in comparison with the WT control MEFs (Table S1 ). As expected, one of the main functions affected by E2F3 LQ mutation is related to metabolism, which includes multiple components of the transport proteins, ROS and redox regulators, and metabolic enzymes (Table S2) . Unexpectedly, the top functions affected by E2F3 LQ mutation are related to inflammation, immunity, and response to stress (Table S2 ). These include multiple cytokines, chemokines, NF-КB regulators, modulators and targets of proinflammatory signaling, and angiogenesis regulators. The expression of some of the genes involved in these categories was further characterized by RT-PCR. As shown in Fig. 5C -K, expressions of SLC7A11 (a component of anionic amino acid transport system that is highly specific for cysteine and glutamate), SRXN1 (sulfiredoxin, a redox protein), UGT1A6A (UDP glucuronosyltransferase), CXCL1 (chemokine), IL1RL1 (a member of the interleukin 1 receptor family), NF-КBIE (inhibitor of NF-КB), PPBP (CXC family chemokine), PTX3 (pentraxin 3, which is induced by inflammatory cytokines and serves as a biomarker for several inflammatory conditions), and VEGFC (VEGF, angiogenesis) are all significantly increased in the proliferating E2F3 LQ MEFs. It should be pointed out that the E2F3 LQ MEFs still had higher expression of the cell cycle and DNA replication targets of E2F, such as CCNE1, CDK1, and MDM2, in the asynchronously proliferating MEFs (Fig. 5L-N) , although the difference in expression is much less than those observed in the serum-starved MEFs observed in Fig. 4E-F . This is not surprising as these E2F targets are repressed in G1 but are highly expressed in S/G2 cells in WT MEFs.
Although several E2F1 mutants were reported previously that disrupt the interactions with Rb, one report showed that the identified E2F1 mutant expressed higher protein levels and the ability to activate E2F target gene was reduced in C-33A cells [19] and the other report showed that most of the mutants moderately reduced reporter activation, although only one CAT assay was shown and the protein levels were not determined [28] . In this report, we tested the hypothesis that the conserved E2F LQ mutation that makes E2F su89 to be Rb-independent in flies [18] will also make the mammalian activating E2Fs to be Rb-independent. The results shown in this report strongly support this idea. Therefore, the E2F LQ mutations will be nice tool to investigate the in vivo consequences of disrupting the interactions between Rb family and an individual E2F.
The observed increased cell cycle regulator and DNA replication factor expression in E2F3 LQ MEFs are consistent with the more rapid G1/S transition of the E2F3 LQ MEF cells. Interestingly, E2F3 LQ MEFs increased rate of MEF proliferation and accumulated at high cell density, suggesting that E2F3 LQ affects cell growth and cell communication in addition to S phase. Characterizing the expression of genes altered in E2F3 LQ MEFs revealed that genes involved in metabolism, inflammation, immunity, and response to stress were significantly affected. It is interesting to note that cell proliferation in both the WT and E2F3 LQ MEFs leveled off before reaching confluence when MEFs were seeded in low cell density ( Fig. 5A-B ). We speculate that the cessation of MEF proliferation under such low-density culture condition is not due to contact inhibition but rather due to the limiting amount of factors, including factors secreted by MEFs. An interesting possibility is that the secreted factors regulating inflammation and stress response enriched in E2F3 LQ MEFs may contribute to the observed increased proliferation of E2F3 LQ MEFs. Further studies will be needed to determine how E2F3 LQ leads to the activation of stress and inflammation-related genes and whether this affects normal and cancer development.
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